衞寧健康(300253.SZ):擬以5000萬元投資慈毅醫療基金
格隆匯7月5日丨衞寧健康(300253.SZ)公佈,為藉助專業投資機構的專業資源及其投資管理優勢,拓展公司醫療健康產業佈局,促進公司長遠發展,公司擬作為有限合夥人以自有資金人民幣5000萬元投資上海慈毅醫療健康股權投資基金合夥企業(有限合夥)(“慈毅醫療基金”、“合夥企業”),公司以認繳出資額為限對合夥企業的債務承擔責任。
合夥企業重點投資於國內腫瘤、腦血管、康復、護理、醫養結合等醫療健康領域的項目,同時可以投資於其他領域的優質項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.